Chevy Chase Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$366M Sell
397,885
-12,596
-3% -$12.8M 1.05% 15
2025
Q4
$441M Sell
410,481
-3,382
-0.8% -$3.23M 1.19% 13
2025
Q3
$316M Sell
413,863
-7,488
-2% -$5.57M 0.87% 15
2025
Q2
$328M Buy
421,351
+2,518
+0.6% +$1.96M 0.96% 15
2025
Q1
$346M Sell
418,833
-288
-0.1% -$240K 1.11% 15
2024
Q4
$324M Sell
419,121
-9,638
-2% -$7.98M 0.99% 15
2024
Q3
$380M Sell
428,759
-13,123
-3% -$11.8M 1.16% 14
2024
Q2
$400M Sell
441,882
-6,102
-1% -$4.88M 1.28% 10
2024
Q1
$349M Sell
447,984
-3,322
-0.7% -$2.36M 1.14% 11
2023
Q4
$263M Sell
451,306
-2,994
-0.7% -$1.75M 0.94% 16
2023
Q3
$244M Sell
454,300
-4,983
-1% -$2.57M 0.96% 16
2023
Q2
$215M Sell
459,283
-4,646
-1% -$1.95M 0.81% 17
2023
Q1
$159M Buy
463,929
+4,529
+1% +$1.53M 0.63% 30
2022
Q4
$168M Sell
459,400
-27,731
-6% -$9.83M 0.71% 29
2022
Q3
$158M Buy
487,131
+5,341
+1% +$1.69M 0.67% 28
2022
Q2
$156M Sell
481,790
-1,496
-0.3% -$449K 0.65% 31
2022
Q1
$138M Buy
483,286
+1,241
+0.3% +$319K 0.48% 40
2021
Q4
$133M Sell
482,045
-48,137
-9% -$12.2M 0.43% 52
2021
Q3
$122M Sell
530,182
-20,461
-4% -$5.05M 0.43% 50
2021
Q2
$126M Sell
550,643
-24,855
-4% -$4.99M 0.43% 50
2021
Q1
$108M Sell
575,498
-37,623
-6% -$7.36M 0.38% 56
2020
Q4
$104M Sell
613,121
-17,247
-3% -$2.58M 0.37% 60
2020
Q3
$93.3M Sell
630,368
-89,265
-12% -$13.8M 0.37% 63
2020
Q2
$118M Sell
719,633
-40,433
-5% -$6.21M 0.48% 43
2020
Q1
$105M Buy
760,066
+12,109
+2% +$1.66M 0.49% 45
2019
Q4
$98.3M Sell
747,957
-4,604
-0.6% -$534K 0.37% 68
2019
Q3
$84.2M Buy
752,561
+25,529
+4% +$2.84M 0.35% 70
2019
Q2
$80.5M Buy
727,032
+842
+0.1% +$99.2K 0.33% 69
2019
Q1
$85.2M Sell
726,190
-55,604
-7% -$6.76M 0.35% 70
2018
Q4
$90.5M Sell
781,794
-8,648
-1% -$966K 0.44% 51
2018
Q3
$84.8M Sell
790,442
-18,839
-2% -$1.88M 0.35% 72
2018
Q2
$69.1M Sell
809,281
-11,411
-1% -$937K 0.3% 82
2018
Q1
$63.5M Sell
820,692
-25,704
-3% -$2.07M 0.28% 85
2017
Q4
$71.5M Sell
846,396
-5,589
-0.7% -$476K 0.31% 80
2017
Q3
$72.9M Buy
851,985
+8,328
+1% +$683K 0.33% 70
2017
Q2
$69.4M Sell
843,657
-1,452
-0.2% -$118K 0.33% 74
2017
Q1
$71.1M Buy
845,109
+24,525
+3% +$1.96M 0.35% 69
2016
Q4
$60.4M Buy
820,584
+3,172
+0.4% +$236K 0.32% 74
2016
Q3
$65.6M Sell
817,412
-19,096
-2% -$1.53M 0.36% 64
2016
Q2
$65.9M Buy
836,508
+8,987
+1% +$677K 0.37% 63
2016
Q1
$59.6M Buy
827,521
+16,640
+2% +$1.26M 0.34% 65
2015
Q4
$68.3M Buy
810,881
+5,743
+0.7% +$477K 0.4% 59
2015
Q3
$67.4M Buy
805,138
+26,978
+3% +$2.28M 0.42% 59
2015
Q2
$65M Buy
778,160
+9,982
+1% +$761K 0.39% 61
2015
Q1
$55.8M Buy
768,178
+25,286
+3% +$1.8M 0.34% 71
2014
Q4
$51.3M Sell
742,892
-19,618
-3% -$1.32M 0.32% 78
2014
Q3
$49.4M Buy
762,510
+44,640
+6% +$2.83M 0.32% 75
2014
Q2
$44.6M Sell
717,870
-14,544
-2% -$868K 0.31% 81
2014
Q1
$43.1M Sell
732,414
-3,979
-0.5% -$222K 0.31% 81
2013
Q4
$37.6M Buy
736,393
+13,077
+2% +$655K 0.27% 90
2013
Q3
$36.4M Buy
723,316
+17,197
+2% +$900K 0.3% 83
2013
Q2
$34.7M Buy
+706,119
New +$38.4M 0.3% 76

Other funds holding LLY

Chevy Chase Trust's LLY Position: Q1 2026 in Review

Chevy Chase Trust reduced its Eli Lilly (LLY) stake by 3.1% in Q1 2026, selling an estimated $12.8M and leaving 397,885 shares worth $366M. The position accounts for 1.05% of the portfolio, ranked #15.

Chevy Chase Trust first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $441M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Chevy Chase Trust held 397,885 shares of Eli Lilly worth $366M as of Q1 2026.
  • Chevy Chase Trust sold 12,596 Eli Lilly shares in Q1 2026, an estimated $12.8M.
  • Eli Lilly made up 1.05% of Chevy Chase Trust's portfolio in Q1 2026, its #15 holding.
  • Chevy Chase Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Chevy Chase Trust's Eli Lilly position peaked at $441M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.